“…The binding of AT-III to the aggregating platelets could then secure the reversibility of the process by preventing further damage to the platelets. Thromboplastin is quickly removed from the blood by its passage through the lungs, and the short ened coagulation times of the circulating blood are caused by coagulation-enhancing serum factors, which are slowly eliminated by the liver [15][16][17], In addition, the pregnant women has an increased sensitivity to stimuli known to induce disseminated intravascular coagulation, such as the Shwartzman reaction [18] or conditions grouped as 'syn drome of late pregnancy' [19], Experimentally, pregnant mice were found to be more sensitive to the injection of thromboplastin than non-pregnant mice [20,21]. Hence, thrombosis-inducing stimuli, which the normal body is able to deal with, may have serious consequences in pregnant women.…”